Skip to main content
. 2020 Jan 13;9:1426. doi: 10.3389/fonc.2019.01426

Figure 6.

Figure 6

Decision curve analysis for the competing risks nomogram for 15-year second primary cancer risks in the validation cohort. The X-axis is the risk threshold probability that changes from 0 to 1 (right truncated at 0.25) and the Y-axis is the calculated net benefit for a given threshold probability. The dashed lines depict the net clinical benefit of the competing risks–based selection strategy for intervention, whereas the gray and black curves display the net benefits in the alternative strategies of treating all patients (gray) vs. treating no patients (black) in the cohort.